U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says
Summary
The U.S. Food and Drug Administration (FDA) decided not to review Moderna's new mRNA flu vaccine. This decision concerns many people because trials showed the vaccine was safe and effective.Key Facts
- The FDA chose not to review Moderna's mRNA flu vaccine.
- The vaccine had gone through late-stage trials successfully.
- These trials showed the vaccine was both safe and effective.
- Concerns arose about the government’s approach to vaccines.
- Amna Nawaz and Michael Osterholm discussed the situation further.
- This decision is linked to the policies of the Trump administration.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
